Fabio Bessa Lima

Fabio Bessa Lima

Auto-generated profile, based on publicly available information

Fabio Bessa Lima

Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Jornal de Pediatria
Verified
Journal Article
Open access
PDF file
MFMiriam Helena Fonseca-Alaniz
Miriam Helena Fonseca-Alaniz
JTJulie Takada
Julie Takada
MAMaria Isabel Cardoso Alonso-Vale
Maria Isabel Cardoso Alonso-Vale
FLFabio Bessa Lima
Fabio Bessa Lima
OBJETIVOS Mostrar os avanços na pesquisa sobre o papel fisiológico do tecido adiposo branco, ressaltando o seu papel endócrino em processos inflamatórios, no comportamento alimentar, na sensibilização à insulina e na modulação do processo de aterogênese. Abordar o potencial papel do tecido adiposo como fonte de células-tronco para regeneração de tecidos, com especial ênfase para a adipogênese e suas conseqüências para a geração de obesidade. FONTES DE DADOS: Informações importantes constantes da literatura científica foram compiladas de modo a que esta leitura contenha uma síntese esclarecedora dos aspectos mencionados acima. SÍNTESE DOS DADOS:O tecido adiposo possui, além das suas funções clássicas como principal estoque de energia metabólica, suprindo as necessidades energéticas em períodos de carência mediante a lipólise, a capacidade de sintetizar e secretar vários hormônios, as adipocinas. Estas agem em diversos processos, como o controle da ingestão alimentar (leptina) e o controle da sensibilidade à insulina e de processos inflamatórios (TNF-alfa, IL-6, resistina, visfatina, adiponectina). Além disso, como o tecido adiposo contém também células indiferenciadas, tem a habilidade de gerar novos adipócitos, regenerando o próprio tecido (adipogênese), bem como originar outras células (mioblastos, condroblastos, osteoblastos), fato este que tem grande potencial terapêutico em futuro não muito distante. CONCLUSÃO: Amplia-se o leque de possibilidades funcionais do tecido adiposo. A compreensão dessas potencialidades pode fazer deste tecido o grande aliado no combate de moléstias que atualmente vêm assumindo proporções epidêmicas (obesidade, diabetes melito, hipertensão arterial e arteriosclerose), nas quais o tecido adiposo ainda é tido como um grande vilão.

6 November 2007 in Jornal de Pediatria
Verified
Journal Article
Closed access
MFMiriam Helena Fonseca-Alaniz
Miriam Helena Fonseca-Alaniz
JTJulie Takada
Julie Takada
MAMaria Isabel Cardoso Alonso-Vale
Maria Isabel Cardoso Alonso-Vale
FLFabio Bessa Lima
Fabio Bessa Lima
To describe the advances in research into the physiological role of white adipose tissue, with emphasis on its endocrinal role in inflammatory processes, feeding behavior, insulin sensitization and modulation of the atherogenetic process. To deal with the potential role of adipose tissue as a source of stem cells for regeneration of tissues, with special emphasis on adipogenesis and its consequences for development of obesity. Important information was compiled from the scientific literature in order that this analysis contains an explanatory synthesis of the aspects mentioned above. SUMMARY OF THE FINDINGS In addition to its classical functions as primary metabolic energy store, meeting energy requirements during periods of deprivation by means of lypolisis, adipose tissue also has the capacity to synthesize and secrete a variety of hormones - the adipokines. These are active in a range of processes, such as control of nutritional intake (leptin) and control of sensitivity to insulin and inflammatory processes (TNF-alpha, IL-6, resistin, visfatin, adiponectin). Furthermore, since adipose tissue also contains undifferentiated cells, it has the ability to generate new adipocytes, regenerating its own tissue (adipogenesis), and also the ability to give rise to other cells (myoblasts, chondroblasts, osteoblasts), which has great therapeutic potential in the not-too-distant future. The range of functional possibilities of adipose tissue has widened. An understanding of these potentials could make this tissue a great ally in the fight against conditions that are currently assuming epidemic proportions (obesity, diabetes mellitus, arterial hypertension and arteriosclerosis) and in which adipose tissue is still seen as the enemy.

18 February 2014 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
APA.R.G. Proença
A.R.G. Proença
RSR.A.L. Sertié
R.A.L. Sertié
AOAriclecio Cunha de Oliveira
Ariclecio Cunha de Oliveira
ACA.B. Campaãa
A.B. Campaãa
RCR.O. Caminhotto
R.O. Caminhotto
FLF.B. Lima
F.B. Lima
Numerous studies address the physiology of adipose tissue (AT). The interest surrounding the physiology of AT is primarily the result of the epidemic outburst of obesity in various contemporary societies. Briefly, the two primary metabolic activities of white AT include lipogenesis and lipolysis. Throughout the last two decades, a new model of AT physiology has emerged. Although AT was considered to be primarily an abundant energy source, it is currently considered to be a prolific producer of biologically active substances, and, consequently, is now recognized as an endocrine organ. In addition to leptin, other biologically active substances secreted by AT, generally classified as cytokines, include adiponectin, interleukin-6, tumor necrosis factor-alpha, resistin, vaspin, visfatin, and many others now collectively referred to as adipokines. The secretion of such biologically active substances by AT indicates its importance as a metabolic regulator. Cell turnover of AT has also recently been investigated in terms of its biological role in adipogenesis. Consequently, the objective of this review is to provide a comprehensive critical review of the current literature concerning the metabolic (lipolysis, lipogenesis) and endocrine actions of AT.

6 September 2007 in Obesity
Verified
Journal Article
Closed access
PDF file
MFMiriam H. Fonseca‐Alaniz
Miriam H. Fonseca‐Alaniz
LBLuciana C. Brito
Luciana C. Brito
CBCristina N. Borges‐Silva
Cristina N. Borges‐Silva
JTJulie Takada
Julie Takada
SASandra Andreotti
Sandra Andreotti
FLFabio B. Lima
Fabio B. Lima

9 October 2008 in Journal of Pineal Research
Verified
Journal Article
Closed access
MAMaria Isabel Cardoso Alonso-Vale
Maria Isabel Cardoso Alonso-Vale
SASandra Andreotti
Sandra Andreotti
PMPaula Yuri Mukai
Paula Yuri Mukai
CBCristina das Neves Borges‐Silva
Cristina das Neves Borges‐Silva
SPSidney Barnabé Peres
Sidney Barnabé Peres
FLFabio Bessa Lima
Fabio Bessa Lima

1 April 2005 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MAMaria Isabel Cardoso Alonso-Vale
Maria Isabel Cardoso Alonso-Vale
SASandra Andreotti
Sandra Andreotti
SPSidney Barnabé Peres
Sidney Barnabé Peres
GAGabriel Anhe
Gabriel Anhe
CBCristina das Neves Borges-Silva
Cristina das Neves Borges-Silva
FLFabio Bessa Lima
Fabio Bessa Lima
Leptin and melatonin play an important role in the regulation of body mass and energy balance. Both hormones show a circadian rhythm, with increasing values at night. In addition, melatonin receptors were recently described in adipocytes, where leptin is synthesized. Here, we investigated the influence of melatonin and its interaction with insulin and dexamethasone on leptin expression. Isolated rat adipocytes were incubated with melatonin (1 nM) alone or in combination with insulin (5 nM) and/or dexamethasone (7 nM) for 6 h. Melatonin or insulin alone did not affect leptin expression, but together they increased it by 120%. Dexamethasone increased leptin mRNA content (105%), and this effect was not enhanced by melatonin. Simultaneous treatment with the three hormones provoked a further increase in leptin release (250%) and leptin mRNA (100%). Melatonin prevented the forskolin-induced inhibition (95%) of leptin expression. In addition, melatonin's ability to stimulate leptin release (in the presence of insulin) was completely blocked by pertussis toxin and luzindole. To gain further insight into the molecular basis of melatonin and insulin synergism, the insulin-signaling pathway was investigated. Melatonin increased the insulin-induced insulin receptor-β tyrosine phosphorylation, which led to an increased serine phosphorylation of the downstream convergent protein Akt. We concluded that melatonin interacts with insulin and upregulates insulin-stimulated leptin expression. These effects are caused by melatonin binding to the pertussis toxin-sensitive Giprotein-coupled membrane receptor (MT1subtype) and the cross talk with insulin, since insulin receptor and its convergent target Akt are coactivated by melatonin.